CD22通过增强质膜钙-ATP酶活性来减弱钙信号传导。
CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity.
作者信息
Chen Jie, McLean Paul A, Neel Benjamin G, Okunade Gbolahan, Shull Gary E, Wortis Henry H
机构信息
Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
出版信息
Nat Immunol. 2004 Jun;5(6):651-7. doi: 10.1038/ni1072. Epub 2004 May 9.
Binding of antigen to the B cell receptor induces a calcium response, which is required for proliferation and antibody production. CD22, a B cell surface protein, inhibits this signal through mechanisms that have been obscure. We report here that CD22 augments calcium efflux after B cell receptor crosslinking. Inhibition of plasma membrane calcium-ATPase (PMCA) attenuated these effects, as did disruption by homologous recombination of the gene encoding PMCA4a and PMCA4b. PMCA coimmunoprecipitated with CD22 in an activation-dependent way. CD22 cytoplasmic tyrosine residues were required for association with PMCA and enhancement of calcium efflux. Moreover, CD22 regulation of efflux and the calcium response required the tyrosine phosphatase SHP-1. Thus, SHP-1 and PMCA provide a mechanism by which CD22, a tissue-specific negative regulator, can affect calcium responses.
抗原与B细胞受体的结合会引发钙反应,这是增殖和抗体产生所必需的。CD22是一种B细胞表面蛋白,其通过一些尚不明确的机制抑制这一信号。我们在此报告,CD22在B细胞受体交联后会增强钙外流。抑制质膜钙ATP酶(PMCA)可减弱这些效应,通过同源重组破坏编码PMCA4a和PMCA4b的基因也会如此。PMCA以激活依赖的方式与CD22共免疫沉淀。CD22胞质酪氨酸残基是与PMCA结合及增强钙外流所必需的。此外,CD22对钙外流和钙反应的调节需要酪氨酸磷酸酶SHP-1。因此,SHP-1和PMCA提供了一种机制,通过该机制,组织特异性负调节因子CD22能够影响钙反应。